This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD).  Never has the impact of one organ system on the other been so profound, as in the current context of  cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of  interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a  significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes 

This book assembles the collective expertise of several  international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized  complications with high morbidity such as athero-embolic renal disease are  featured prominently, to increase awareness in the interventional cardiology and nephrology communities. 

This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this  textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease. 

Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes

Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions
Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
Cardiovascular impact of Atherosclerotic Renovascular Disease
Platelet Function testing and antiplatelet agent choice in CKD
Choice of stents and clinical outcomes in patients with CKD
Revascularization strategies in CKD: PCI vs CABG
Approach to revascularization in the potential kidney transplant recipient
Nephrology consultative approach and risk stratification prior to revascularization in CKD
Contrast Induced AKI: Epidemiology, risk stratification and prognosis
Contrast induced AKI: Pathophysiological Mechanisms
Prevention of Contrast Induced AKI: Summary of volume optimization strategies
Prevention of Contrast induced AKI:  Contrast medium selection, adjuvant strategies andbest clinical practices
Intra procedural and operator strategies for reduction of contrast induced AKI
Effect of Percutaneous Ventricular Assist Devices on Renal Function
Renal athero-embolic disease: An underdiagnosed entity
Acute kidney injury with trans catheter aortic valve replacement
Impact of kidney disease in catheter based mitral valve interventions
Acute kidney injury with peripheral vascular interventions
Renal Artery Stenosis:  State of the Art in Diagnosis and Management
Renal Denervation: Physiology, scope and current evidence
Economic impact of AKI and CKD in cardiac interventions
Biomarkers in early risk stratification and management of post catheterization AKI
Utilization of the cardio nephrology collaborative in the era of value based medicine.